Mazdutide is an investigational dual agonist of GLP-1 and glucagon receptors, researched for its potential in weight management and metabolic health. Studies suggest it may promote significant fat loss, improve insulin sensitivity, enhance glucose control, and positively influence cardiovascular risk factors. Its dual-receptor activity aims to combine appetite suppression with increased energy expenditure for enhanced metabolic outcomes.